Lialda

— THERAPEUTIC CATEGORIES —
  • Colorectal disorders

Lialda Generic Name & Formulations

General Description

Mesalamine 1.2g; del-rel tabs.

Pharmacological Class

Aminosalicylate.

How Supplied

Tabs—120

Generic Availability

YES

Lialda Indications

Indications

For induction and maintenance of remission in adults with mildly to moderately active ulcerative colitis. To treat mildly to moderately active ulcerative colitis in pediatric patients weighing ≥24kg.

Lialda Dosage and Administration

Adult

Swallow whole with food. Induction: 2.4–4.8g once daily. Maintenance: 2.4g once daily.

Children

<24kg: not established. Swallow whole with food. Take once daily. 24–35kg (Weeks 0 to 8): 2.4g; (after Week 8): 1.2g. >35–50kg (Weeks 0 to 8): 3.6g; (after Week 8): 2.4g. >50kg (Weeks 0 to 8): 4.8g; (after Week 8): 2.4g.

Lialda Contraindications

Not Applicable

Lialda Boxed Warnings

Not Applicable

Lialda Warnings/Precautions

Warnings/Precautions

Sulfasalazine allergy. Upper GI tract obstruction (eg, pyloric stenosis) may delay onset of action. Discontinue if acute intolerance syndrome is suspected. Discontinue at the 1st signs/symptoms of severe cutaneous adverse reactions. Conditions predisposing to myocarditis or pericarditis. Atopic dermatitis or eczema: may have more severe photosensitivity reactions. Nephrolithiasis. Ensure adequate hydration. Renal or hepatic impairment. History of renal disease. Assess renal function prior to and periodically during therapy. Discontinue if renal function deteriorates while on therapy. Elderly (monitor CBCs, platelets). Pregnancy. Nursing mothers: monitor infants.

Lialda Pharmacokinetics

Metabolism

Hepatic.

Elimination

Renal.

Lialda Interactions

Interactions

Increased toxicity with nephrotoxic drugs (eg, NSAIDs). Increased risk for blood disorders, bone marrow failure, and associated complications with azathioprine or 6-mercaptopurine and/or other drugs known to cause myelotoxicity. May cause elevated test results when measuring urinary normetanephrine.

Lialda Adverse Reactions

Adverse Reactions

Headache, flatulence, abnormal LFTs, abdominal pain, diarrhea; children also: upper RTI, vomiting, anemia, viral infection; acute intolerance syndrome (cramping, bloody diarrhea, fever, headache, rash), renal impairment, hypersensitivity reactions, severe cutaneous adverse reactions (eg, SJS, TEN, DRESS, AGEP); rare: pancreatitis.

Lialda Clinical Trials

See Literature

Lialda Note

Not Applicable

Lialda Patient Counseling

See Literature